ABOUT THIS WEBINAR This webinar will: - Provide a general overview of the Bioresearch Monitoring (BIMO) program
- Discuss Good Clinical Practice (GCP) inspectional processes, compliance evaluation and enforcement, including case examples
- Summarize findings from a recent publication on follow-up inspectional activities after FDA notifies an inspected entity of serious noncompliance
- Include live Q&A session and a moderated panel discussion
INTENDED AUDIENCE - Clinical investigators
- Clinical research personnel (e.g., sub-investigators, study coordinators, regulatory specialists)
- Sponsors, Contract Research Organizations (CROs)
- Sponsor-Investigators
- Institutional Review Board (IRBs)
| | TOPICS COVERED - Overview of CDER's GCP BIMO Program
- GCP inspections, including classification criteria, and case examples of serious noncompliance
- Official Action Indicated (OAI) follow-up inspection procedures, findings, and trends
| |
No comments:
Post a Comment